Back to Annual Meeting Page
|
133rd Annual Meeting & Exposition December 10-14, 2005 Philadelphia, PA |
||
Paige L. Bordelon, MPH1, James M. Musser, MD, PhD2, and Edward A. Graviss, PhD, MPH2. (1) Epidemiology, University of Texas School of Public Health at Houston, 1200 Herman Pressler, Houston, TX 77030, 713-500-9000, Paige.L.Bordelon@uth.tmc.edu, (2) Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Texas Medical Center, Houston, TX 77030
OBJECTIVE: To determine if drug users with tuberculosis (TB) in a large urban United States county, differ from non-drug users with TB with respect to socio-demographic and behavioral factors as well as clinical presentation and microbiological molecular features. DESIGN: A population-based nested case-control study using data obtained from the Houston Tuberculosis Initiative (HTI). RESULTS: We found that among 2,023 TB patients, variables that were associated with illicit drug users in a multivariate model were individuals being less than 50 years of age, having been born in the U.S., self-identifying a history of prison incarceration, having a history of participating in an alcohol detoxification program, and having sex partners that use crack/cocaine. CONCLUSION: Drug users who have TB differ from non-drug users who have TB in several key demographic and behavioral variables. The illicit drug using population represents a population whose lifestyle puts them at increased risk for becoming infected with and developing TB disease. It is therefore important for public health efforts to focus on this high-risk group with targeted TB screening and control efforts.
Learning Objectives:
Keywords: Tuberculosis, Drug Use
Presenting author's disclosure statement:
I wish to disclose that I have NO financial interests or other relationship with the manufactures of commercial products, suppliers of commercial services or commercial supporters.
The 133rd Annual Meeting & Exposition (December 10-14, 2005) of APHA